Veristat’s Post

Exciting to share the below webinar #CRALifeSciences is hosting in a couple of weeks' time on the evolving business models in digital therapeutics. See the link to learn more and register! #DigitalTherapeutics

If any industry should be human-centric, it's healthcare. For anyone in a healthcare-related industry, check out our upcoming webinar on how to practically incorporate a greater degree of patient-centricity into your approach.

Learn how utilizing robust data and analytics platforms, such as TriNetX enables companies like Sanofi to assess patient population and optimize their cohorts for diverse representation. Read the full article: https://ow.ly/V18l30sG3TW Access our diversity resources for better patient outcomes: ow.ly/lOVq30szIq8

Our team have had a busy few days at BIO-Europe Spring this week, connecting with both new and existing customers. Marianna Sciortino shares some key highlights from the conference. Missed us at BIO-Europe? Book an exploratory meeting with one of our solution experts using the link below to: ·  Learn more about how our Physician Engage services enables you to identify and engage physicians at the optimum time in the treatment decision window to increase patient identification and support therapy adoption. ·  Discover how Diaceutics Market Landscape can optimize your commercial strategy by providing insights into the testing landscape, driving test adoption for your precision medicine diagnostic. ·  Find out more about our Lab Engage services that enable you to communicate directly with labs, utilizing our global lab network to influence biomarker testing behaviors and drive testing rates. https://lnkd.in/duuUdunz #BIOEuropeSpring

What an incredible journey 2024 has been for QIAstat-Dx! At QIAGEN, we’ve made strides this year that I’m truly proud to share:   ✅ Launched the QIAstat-Dx Analyzer 2.0, bringing remote test result access and collaboration tools to healthcare teams worldwide.   ✅ Earned FDA clearance for four new panels, empowering clinicians to deliver faster, tailored diagnostic insights for respiratory, gastrointestinal, and neurological conditions.   ✅ Achieved IVDR certification in Europe, ensuring compliance and excellence in diagnostics for critical infections.   ✅ Ventured into precision medicine, collaborating with partners like Eli Lilly and Astra Zeneca to advance diagnostics for hereditary diseases.   This progress reflects the relentless dedication of our teams, the power of collaboration, and our shared mission to make improvements in life possible.   To our partners, healthcare professionals, and colleagues across the globe – thank you for being part of this journey. Together, we’re shaping the future of healthcare, one breakthrough at a time.   Here’s to even greater achievements in 2025!   #QIAGEN #QIAstatDx #Diagnostics #PrecisionMedicine #Healthcare

Data is powerful, but stories are unforgettable." We develop compelling case studies that showcase real-world scenarios and successful patient outcomes. Inquire at carbongroup.in #casestudy #casestidies #patientcasestudy #patientcasestudies #medicalinput #medicalinputs #pharmavisualaid #pharmavisualaids #pharmaceuticalvisualaid #pharmaceuticalvisualaids #medicalvisualaid #medicalvisualaids #pharmacontentmarketing #pharmaceuticalcontentmarketing #medicalcontentmarketing #pharmabranding #pharmaceuticalbranding #medicalcommunication #medicalcommunications #carbonbrandsolutions

It's time for our Citeline Monthly Highlights! Here are some of September's latest news and updates from our Citeline brands. Check out the links below. 👇 We are proud to join forces with Greenphire, this partnership is a huge step in how we will create next generation products at Citeline. Read how our complementary datasets will support sponsors and CROs in clinical trial planning! https://ow.ly/nUg050TEfzo. Citeline Connect seamlessly blends technology and services to expand recruitment channels and accelerate study enrollment. This integrated, modular solution can be tailored to specific needs so you can effortlessly meet your enrollment targets: https://ow.ly/JAOm50TEfzm. Ensuring reliable disclosure practices has evolved beyond a mere regulatory requirement for clinical trial professionals. Is your organization keeping up? Find out in the first of our clinical trial disclosure maturity model series: https://ow.ly/p2eH50TEfzk. Founder of autism therapy digital therapeutic firm Floreo, spoke to Medtech Insight about working with the FDA and why the TAP pilot made sense for them: https://ow.ly/xC7U50TEfzn. Don't miss our upcoming webinar: Unlock Global Access to Advanced Therapies! Join us on October 9 to discover how data insights can break down barriers in middle and low-income countries, expanding access to critical CGTs: https://ow.ly/MLGk50TEfzl.

This week, Bara Badwan is representing us on the West Coast at The Alliance for Artificial Intelligence in Healthcare (AAIH) and sharing our work on how our patented #AI solution identifies promising early-stage #biopharma assets and companies. You can read more about that here: https://lnkd.in/eTJReqfj. #pharmaceutical #portfoliostrategy

🚨 Attention biotech research and investor community: CureSHANK is hosting an Open House at JPM next week (Tuesday, see details below). Key facts about Phelan-McDermid syndrome / SHANK3 haploinsufficiency: ➡️ Incidence about 1 in 15,000 (like Angelman syndrome) ➡️ Genetic haploinsufficiency mapping into the neurodevelopmental/autism/DEE space ➡️ Clinical pipeline: one advanced symptomatic program starting Phase 3, one gene therapy starting Phase 1/2 The CureSHANK Foundation wants to broaden the pipeline and accelerate the speed of treatment development and will be meeting people at JPM Reach out to Brett Abrahams if you are interested!

Innovations like virtual health communities, digital therapeutics, and on-demand lab tests are transforming the healthcare landscape. Here are five trends to know: https://okt.to/wXNc1G #DKSH #DKSHInsights #digitalhealth #virtualhealth #healthcaresolutions